Upregulation of the Arp2/3 subunit, ARPC1B, is associated with very poor metastasis‐free survival of breast cancer patients, but inhibition of ARP2/3 prevents cycle progression through RAC1 transformation [7, 25]. The gene discussed is RAC1; the disease is breast carcinoma.